Ferritin in Acute Myeloid Leukemia: Not Only a Marker of Inflammation and Iron Overload, but Also a Regulator of Cellular Iron Metabolism, Signaling and Communication
International Journal of Molecular Sciences · 15.06.2025 · 26 (12) · 5744
DOI: 10.3390/ijms26125744 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.06.2025. Verfasst von Håkon Reikvam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Ferritins, Iron, Iron Overload. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 336 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ferritin is important for cellular iron storage and metabolism. It consists of 24 ferritin heavy- or light-chain subunits surrounding an iron-containing core, but it is also released as an extracellular molecule that shows increased systemic levels during acute-phase reactions. Furthermore, acute myeloid leukemia (AML) is an aggressive bone marrow malignancy that can be associated with increased ferritin levels both at the time of first diagnosis but also during/following anti-AML treatment due to an iron overload. Such high systemic ferritin levels at diagnosis or later allogeneic stem cell transplantation are associated with decreased long-term survival. Extracellular ferritin binds to several receptors expressed by AML cells (e.g., the transferrin receptor and CXCR4 chemokine receptor) and AML-supporting non-leukemic bone marrow cells (e.g., endothelial, mesenchymal or immunocompetent cells). Ferritin can thereby affect the AML cells directly as well as indirectly via AML-supporting neighboring cells. Finally, ferritin should be regarded as a regulator of the dysfunctional iron metabolism that causes increased iron levels in AML cells, and it is important for cell survival through its function during the initial steps of ferroptosis. Thus, ferritin is not only an adverse prognostic biomarker, but also an important regulator of AML cell proliferation, survival and chemosensitivity and the targeting of iron metabolism/ferroptosis is, therefore, a possible strategy in AML therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.
- Section for Hematology, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
- Department of Medicine, Akershus University Hospital, Postboks 1000, 1478 Lørenskog, Norway.
- Proteomics Unit of University of Bergen (PROBE), University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
- Department of Physical Chemistry, University of Granada, Avenida de la Fuente Nueva S/N, 18071 Granada, Spain.
- Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.
ORCID-Profile: Håkon Reikvam, Maria Hernandez-Valladares
Zitieren
APA
Reikvam, H., Rolfsnes, M. G., Rolsdorph, L., Sandnes, M., Selheim, F., Hernandez-Valladares, M., & Bruserud, Ø. (2025). Ferritin in Acute Myeloid Leukemia: Not Only a Marker of Inflammation and Iron Overload, but Also a Regulator of Cellular Iron Metabolism, Signaling and Communication. International Journal of Molecular Sciences, 26(12), 5744. https://doi.org/10.3390/ijms26125744
Vancouver
Reikvam H, Rolfsnes MG, Rolsdorph L, Sandnes M, Selheim F, Hernandez-Valladares M, et al. Ferritin in Acute Myeloid Leukemia: Not Only a Marker of Inflammation and Iron Overload, but Also a Regulator of Cellular Iron Metabolism, Signaling and Communication. International Journal of Molecular Sciences. 2025;26(12):5744. doi:10.3390/ijms26125744
BibTeX
@article{Reikvam2025,
author = {Reikvam, Håkon and Rolfsnes, Magnus Gramstad and Rolsdorph, Linn and Sandnes, Miriam and Selheim, Frode and Hernandez-Valladares, Maria and Bruserud, Øystein},
title = {Ferritin in Acute Myeloid Leukemia: Not Only a Marker of Inflammation and Iron Overload, but Also a Regulator of Cellular Iron Metabolism, Signaling and Communication},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {12},
pages = {5744},
doi = {10.3390/ijms26125744}
}
EUVIMED